Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 2/2021

01-02-2021 | Geriatric Assessment | Correction

Correction to: Comprehensive geriatric assessment and decision-making in older men with incurable but manageable (chronic) cancer

Authors: Catherine Handforth, Roger Burkinshaw, Jenny Freeman, Janet E. Brown, John A. Snowden, J. Fearnside, Robert E. Coleman, Diana M. Greenfield

Published in: Supportive Care in Cancer | Issue 2/2021

Login to get access

Excerpt

Supportive Care in Cancer (2019) 27:1755–1763 …
Metadata
Title
Correction to: Comprehensive geriatric assessment and decision-making in older men with incurable but manageable (chronic) cancer
Authors
Catherine Handforth
Roger Burkinshaw
Jenny Freeman
Janet E. Brown
John A. Snowden
J. Fearnside
Robert E. Coleman
Diana M. Greenfield
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05893-0

Other articles of this Issue 2/2021

Supportive Care in Cancer 2/2021 Go to the issue

Original Article

Psychosocial distress in patients with cutaneous melanoma: validation of the Skin Cancer Index (SCI)

Original Article

Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin

Original Article

Poor sleep quality among newly diagnosed head and neck cancer patients: prevalence and associated factors

Commentary

Rapid deployment of virtual mind-body interventions during the COVID-19 outbreak: feasibility, acceptability, and implications for future care

Original Article

Communication in surgical decision-making while managing metastatic bone disease: matching patient expectations with surgical goals

Original Article

Antifungal prophylaxis during 7 + 3 induction chemotherapy for acute myeloid leukemia is associated with improved survival, in a setting with low incidence of invasive mold infections
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits